Uždaroji akcinė bendrovė "Pharmcos" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
441 |
175 |
-9,325 |
-9,325 |
-3,700 |
100.00 |
-2,114.51 |
-268,795 |
304,819 |
35 |
35,989 |
2022 |
---|
31,438 |
15,719 |
-5,364 |
-5,364 |
-2,682 |
100.00 |
-17.06 |
-274,159 |
295,683 |
35 |
21,489 |
2023 |
---|
0 |
0 |
-3,864 |
-3,864 |
-1,932 |
- |
- |
-278,023 |
299,547 |
35 |
21,489 |
Register and
explore Okredo data2023 |
---|
0 |
0 |
-3,864 |
-3,864 |
-1,932 |
- |
- |
-278,023 |
299,547 |
35 |
21,489 |
Register and
explore Okredo data2023
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
-3,864 €28 % *
Net Profit (€)
-3,864 €28 % *
Profit per employee (€)
-1,932 €28 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
-278,023 €-1 % *
Amounts Payable And Liabilities (€)
299,547 €1 % *
Non-current Assets (€)
35 €0 % *
CurrentAssets (€)
21,489 €0 % *